Unilabs News | Unilabs

Unilabs News

For media enquiries, please use our contact form.

Media Release
3 November 2022
Unilabs and RIMED join forces in Switzerland to expand their position in the field of integrated medical diagnostics
Unilabs, a leading diagnostic services provider, and RIMED, a leading Swiss diagnostic radiology company, announced today a unique partnership that will enable patients and referring facilities in Switzerland to benefit even more from integrated medical diagnostics.
Media Release
18 October 2022
Unilabs bets on innovation and sustainability to transport its medical samples
A drone with a capacity for 150 lab tubes cuts transport time between Coppet and Geneva labs by more than 90 minutes and net carbon footprint and fine particles emission by more than 95%
Media Release
14 September 2022
Unilabs Selects Proscia’s AI For Skin Pathology
The diagnostic services provider projects DermAI may decrease turnaround time for melanoma cases by 30-40%
Media Release
8 September 2022
Unilabs expands its diagnostic portfolio and offers monkeypox testing
Unilabs, a leading diagnostic services provider, has expanded its portfolio and performs monkeypox tests to address the current global health concern. The group is ready to perform this test in France, Spain, Portugal, and the UAE and will extend this service across its entire network pending regulatory green light.
Media Release
1 September 2022
Unilabs will be present at the 34th European Congress of Pathology in Basel
Unilabs, a leading diagnostic services provider, will participate in the 34th European Congress of Pathology that will take place in Basel between 3 and 7 September. Participants can visit Unilabs’ pathologists at the booth 2F12.
Media Release
1 August 2022
Unilabs appoints Shalinee Basak as Group Chief HR Officer
Unilabs, a leading diagnostic services provider, has appointed Shalinee Basak as Group Chief HR Officer. Basak will report to Michiel Boehmer, Unilabs’ CEO, and be part of the Unilabs Executive Management Team. She will be based in Geneva.
Media Release
13 July 2022
Unilabs signs on Qure.ai for triaging chest X-rays
Unilabs, the leading diagnostic services provider, announced a partnership with Qure.ai, a market leader in medical artificial intelligence (AI) solutions. Through this partnership, Unilabs will be deploying Qure's AI solution to aid in the classification of chest X-rays into normal and abnormal exams. The solution will initially be implemented and piloted in Unilabs TMC's Elective UK Service arm to help increase the capacity and optimise radiology workflow.
Media Release
6 July 2022
Unilabs Sweden Launches Subtle Medical’s AI-powered Imaging Technology to Further Bolstering Patient Care
Unilabs, the leading diagnostic services provider, announced a partnership with Subtle Medical, a healthcare technology company using artificial intelligence for faster and higher quality MRI, to further improve the quality and efficiency of their MRI imaging. The solution, which will first be rolled out in Sweden, will boost Unilabs’ MRI programme to provide industry-leading productivity and an even more superior patient experience.
Media Release
30 June 2022
Unilabs uses Mindpeak’s AI software in the clinical routine
Unilabs, the leading diagnostic services provider, now brought Mindpeak’s AI solutions into the clinical routine to speed up breast cancer diagnosis and make it more accurate.
Media Release
9 June 2022
Unilabs will be present at the European Human Genetics Conference in Vienna
Unilabs, the leading European diagnostic services provider, will participate in Vienna’s European Human Genetics Conference that will take part between 11 and 14 June. Participants can visit Unilabs’ geneticists at booth X4-760.
Blog
11 May 2022
Three reasons why digital pathology is crucial in the fight against cancer
Since March 2020, Covid has been making headlines around the world. But there is an older scourge that continues to grow: cancer. Every year, more than 18 million new cases are diagnosed, and 9.6 million people die from the disease. According to the World Health Organisation, cancer will affect 29.5 million people a year by 2040. Fortunately, early diagnosis allows less invasive, shorter, and more effective treatment.